Table 1.
Total ADRs reported in EV related to DOACs.
| Drug | Total ADRs | % of Total |
|---|---|---|
| Dabigatran | 57,627 | 13.49% |
| Rivaroxaban | 131,182 | 30.70% |
| Apixaban | 70,424 | 16.48% |
| Edoxaban | 9318 | 2.18% |
| Other ACs | 158,767 | 37.15% |
| 427,318 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.